Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical lactic acid gel vs oral metronidazole for recurrent bacterial vaginosis
2016-004483-19Phase 3Completed
- Sponsor
- University Hospitals Birmingham
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of lactic acid in bacterial vaginosis (BV) (2 arms), sponsored by University Hospitals Birmingham. Primary endpoint: Symptomatic resolution of bacterial vaginosis at week 2. Started May 2018; status: completed.
02
Drugs
lactic acid
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on 2016-004483-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004483-19.